INSIGHTS ON CELL & GENE OUTSOURCING ISSUES
-
Ramp Up Your AAV Production With The Xcite® AAV Platform Technology
Xcite™ AAV platform technology is established based on our proprietary suspension HEK293 cell line and plasmid vectors, proven to enhance AAV production.
-
3-Step Plasmid Engineering Service For Complex Plasmids
Explore how fully dedicated plasmid engineering specialists at Polyplus manage your projects from beginning to end, guaranteeing successful assembly and on-time delivery.
-
9 Common Tech Transfer Pitfalls To Avoid
Many issues can trip up a tech transfer process. Here are nine of them— plus ways to mitigate each one.
-
Enhancing AAV Purification: Strategies For Improved Recovery And Quality For Downstream
This study evaluates filter trains from four vendors, aiming to enhance titer recovery, HCP removal, DNA breakthrough, turbidity reduction, and throughput in gene therapy manufacturing.
-
Scalability Of A Flexible, High-Producing Triple-Transfection rAAV Platform
Explore a demonstration of a scalable, high-yield triple-transfection rAAV platform's flexibility and efficiency, enabling gene therapy production with robust performance metrics and streamlined processes.
-
Next Gen rAAV Production – A Scalable Platform To Revolutionize Gene Therapy Manufacturing
See how a next-generation rAAV production platform delivers high yields and superior product quality across various serotypes and genome lengths through innovative process optimization.
-
Building A Chromatography Platform For Purification And Full Capsid Enrichment On AAV8
Developing a robust chromatography platform for AAV8 purification and full capsid enrichment ensures high gene therapy product quality, addressing the challenge of empty capsid removal and enhancing therapeutic efficacy.
-
Delivery Success In Gene Editing: Focusing On Lipid Nanoparticles To Show Effectiveness
Delve into the importance of delivery success in gene editing and review the use of viral vectors and lipid nanoparticles as two approaches to improve this aspect.
-
Next-Generation CRISPR Approaches
By providing essential components like nucleases, gRNAs, and HDR templates, a reliable CDMO facilitates a seamless transition from discovery research to clinical trials and beyond.
-
Mastering The Journey From Initial Method Transfer To Successful Lot Release For Cell & Gene Therapies
View the webinar and learn how efficient project management and optimized communication are cornerstones of a successful transfer process.